Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-065656
Filing Date
2021-11-18
Accepted
2021-11-18 20:10:36
Documents
1
Period of Report
2021-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5894
  Complete submission text file 0001209191-21-065656.txt   7308
Mailing Address C/O AUDENTES THERAPEUTICS, INC. 101 MONTGOMERY ST., SUITE 2650 SAN FRANCISCO CA 94104
Business Address
PARMAR KUSH (Reporting) CIK: 0001664281 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 211426102

Mailing Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)